Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 5Unknown 2Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Recurrence 1Multiple Myeloma 1Leukemia, Myeloid, Chronic-Phase 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Metformin 34Clomiphene 11Letrozole 9Inositol 6Triptorelin Pamoate 5drospirenone and ethinyl estradiol combination 4Progesterone 4Folic Acid 4Ethinyl Estradiol 4Caloric Restriction 4drospirenone 3cetrorelix 3Spironolactone 3Estradiol 3Diet, Mediterranean 3Diet 3Cyproterone acetate, ethinyl estradiol drug combination 3Contraceptives, Oral 3Acupuncture Therapy 3adrenosterone 2Vitamin D 2Ultrasonography 2Thioctic Acid 2Therapeutics 2Sitagliptin Phosphate 2Simvastatin 2Pioglitazone 2Ovidrel 2Musculoskeletal Manipulations 2Hematologic Tests 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Polycystic Ovary Syndrome × Pioglitazone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT05519813 2022-08-29

Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.

Shengjing Hospital

Phase 4 Unknown
60 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡